Source: BioPortfolio

Inotek Pharmaceuticals: Inotek Pharmaceuticals Corp ITEK Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12032018 Prices from USD $250

SummaryInotek Pharmaceuticals Corp IPC is a pharmaceutical company that discovers develops and commercializes therapeutics for the treatment of glaucoma and serious diseases of the eye. The company's trabodenoson is a selective adenosine mimetic that stimu...

Read full article »
Annual Revenue
$100K-5.0M
Employees
250-500
David P. Southwell's photo - President & CEO of Inotek Pharmaceuticals

President & CEO

David P. Southwell

CEO Approval Rating

70/100

Read more